Gapping up
In reaction to strong earnings/guidance: FIVE +7.1%, JOY +1.5%, CEIN +0.6%
M&A news: BRLI +48.7% (OPKO Health (OPK) to acquire Bio-Reference Laboratories in transaction is valued at ~$1.47 bln or $52.58 per share )
Other news: AVEO +30.6% (receives EU regulatory guidance regarding potential MAA for Tivozanib), DARA +27.5% (announces that it has signed a merger agreement with Midatech Pharma, with DARA shareholders receiving Midatech Pharma stock upon transaction closing), NBY +26.5% (announces receipt of 510(k) clearance from the FDA to market its novel intelli-Case with hydrogen peroxide solutions), NEON +8.8% (igned a development and license agreement with Samsung Electronics (SSNLF) to incorporate zForce CORE technology into its printer applications), VISN +7.9% (announces financing transaction for ~$11.5 mln of Series A equity led by Baidu (BIDU) unit), AMPE +7.5% (announces update of STRIDE study for the investigation of pain associated with Osteoarthritis), BH +7.4% ( Lion Fund II announces it has commenced a tender offer for up to 575K shares of BH common stock at $420/share), EYES +7% (disclosed that CGS Administrators, the Medicare Administrative Contractor for Ohio and Kentucky agreed to cover the implantation of the Argus II retinal prosthesis system for the FDA approved indications),TMUS +6.7% (reports it and Dish Network (DISH) are in merger talks), DISH +6.3% (reports TMUS and DISH are in merger talks), FEYE +3.4% (co and Visa to partner to co-develop tools and services to help merchants and issuers protect against advanced cyber attacks targeting payment data), DBVT +3.4% (EMA PDCO positive opinion on the Paediatric Investigation Plan for Viaskin Peanut), FNJN +3% (received favorable rulings on motions for summary judgment, regarding its Blue Coat case), WYNN +2.9% (Credit Suisse pointed to 'green shoots' in this week's gaming data), EXAS +2.9% (Exact Sciences (EXAS) and The University of Texas MD Anderson Cancer Center announced an agreement to jointly develop and commercialize blood-based screening and diagnostic tests for the early detection of lung cancer. ), UTEK +2.8% (announced its Ultratech-CNT business unit has delivered a Phoenix G2 Batch ALD system to a major Japanese manufacturer), LVS +2.6% (Credit Suisse pointed to 'green shoots' in this week's gaming data), CS +2.5% (still checking), MUX +1.9% (filed for $200 mln mixed securities shelf offering),MCGC +1.1% (HC2 Holdings (HCHC) revised proposal to acquire MCG Capital to $5.30/share, up from prior offer of $5.25/share)
Analyst comments: ERIC +3.3% (upgraded to Overweight from Neutral at JP Morgan), FTR +0.9% (upgraded to Outperform from Mkt Perform at Raymond James
)
In reaction to strong earnings/guidance: FIVE +7.1%, JOY +1.5%, CEIN +0.6%
M&A news: BRLI +48.7% (OPKO Health (OPK) to acquire Bio-Reference Laboratories in transaction is valued at ~$1.47 bln or $52.58 per share )
Other news: AVEO +30.6% (receives EU regulatory guidance regarding potential MAA for Tivozanib), DARA +27.5% (announces that it has signed a merger agreement with Midatech Pharma, with DARA shareholders receiving Midatech Pharma stock upon transaction closing), NBY +26.5% (announces receipt of 510(k) clearance from the FDA to market its novel intelli-Case with hydrogen peroxide solutions), NEON +8.8% (igned a development and license agreement with Samsung Electronics (SSNLF) to incorporate zForce CORE technology into its printer applications), VISN +7.9% (announces financing transaction for ~$11.5 mln of Series A equity led by Baidu (BIDU) unit), AMPE +7.5% (announces update of STRIDE study for the investigation of pain associated with Osteoarthritis), BH +7.4% ( Lion Fund II announces it has commenced a tender offer for up to 575K shares of BH common stock at $420/share), EYES +7% (disclosed that CGS Administrators, the Medicare Administrative Contractor for Ohio and Kentucky agreed to cover the implantation of the Argus II retinal prosthesis system for the FDA approved indications),TMUS +6.7% (reports it and Dish Network (DISH) are in merger talks), DISH +6.3% (reports TMUS and DISH are in merger talks), FEYE +3.4% (co and Visa to partner to co-develop tools and services to help merchants and issuers protect against advanced cyber attacks targeting payment data), DBVT +3.4% (EMA PDCO positive opinion on the Paediatric Investigation Plan for Viaskin Peanut), FNJN +3% (received favorable rulings on motions for summary judgment, regarding its Blue Coat case), WYNN +2.9% (Credit Suisse pointed to 'green shoots' in this week's gaming data), EXAS +2.9% (Exact Sciences (EXAS) and The University of Texas MD Anderson Cancer Center announced an agreement to jointly develop and commercialize blood-based screening and diagnostic tests for the early detection of lung cancer. ), UTEK +2.8% (announced its Ultratech-CNT business unit has delivered a Phoenix G2 Batch ALD system to a major Japanese manufacturer), LVS +2.6% (Credit Suisse pointed to 'green shoots' in this week's gaming data), CS +2.5% (still checking), MUX +1.9% (filed for $200 mln mixed securities shelf offering),MCGC +1.1% (HC2 Holdings (HCHC) revised proposal to acquire MCG Capital to $5.30/share, up from prior offer of $5.25/share)
Analyst comments: ERIC +3.3% (upgraded to Overweight from Neutral at JP Morgan), FTR +0.9% (upgraded to Outperform from Mkt Perform at Raymond James
)